Navigation Links
FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
Date:8/14/2012

WALTHAM, Mass., Aug. 14, 2012 /PRNewswire/ -- GeNO LLC (www.genollc.com), a privately held pharmaceutical  company developing a line of inhaled nitric oxide drug products, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for its nitric oxide (delivered via the GeNOsyl MVG-2000 delivery system) for the treatment of persistent pulmonary hypertension in newborns (PPHN).  The orphan drug designation was granted based on a plausible hypothesis for clinical superiority over the approved nitric oxide product.

Orphan Drug designation is granted by the FDA Office of Orphan Drug Products to novel drugs to treat a rare disease or condition affecting fewer than 200,000 persons in the United States.  The designation provides the drug developer with a seven-year period of US marketing exclusivity if the drug is the first of its type approved for the specified indication or if it demonstrates superior safety, efficacy, or a major contribution to patient care versus another drug of its type previously granted the designation for the same indication, as well as with tax credits for clinical research costs, the ability to apply for grant funding, clinical research trial assistance and waiver of filing fees. 

"Our goal is to use our proprietary chemistry and delivery apparatus to provide low-dose inhaled NO that provides a level of purity that cannot be attained with currently available treatments," said GeNO President and Founder Dr. David Fine.  "We believe our technology has the potential to be a transformative therapy for patients suffering from rare diseases like PPHN for whom there are limited treatment options, and we are committed to advancing the clinical and commercial development of our nitric oxide delivery platforms because of the dramatic benefit they may have on the lives of patients.  Orphan Drug Designation of GeNO's drug produ
'/>"/>

SOURCE GeNO LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
2. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
3. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
4. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
5. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
6. NORD Calls Senate Bill Most Important Since Orphan Drug Act
7. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
8. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
9. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
10. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
11. Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)...  Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical ... unmet needs in oncology, autoimmune and inflammatory disease, today ... closing of the NASDAQ Global Market on Tuesday, August ... by Michael Martino , president and CEO, and ... the same day at 5:00 pm EDT (2:00 pm ...
(Date:7/29/2014)... July 29, 2014   Abide Therapeutics ... to its board of directors. Thornberry was ... and Endocrinology for Merck & Co. Inc., where ... pipeline management in diabetes, osteoporosis, fertility and contraception. ... the program that resulted in the discovery of ...
Breaking Medicine Technology:Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
(Date:7/29/2014)... 2014 For survivors of severe combat injuries threatening ... flaps have a good record of safety and effectiveness ... issue of Plastic and Reconstructive Surgery ... Society of Plastic Surgeons (ASPS). , Experience with ... and Afghanistan shows good success rates, with no increase ...
(Date:7/29/2014)... By Randy Dotinga ... (HealthDay News) -- When most children take on a ... less of this neuro-boosting activity in kids with autism, ... with more severe symptoms of autism displayed even less ... ,"This reduced flexibility often causes difficulty when children ...
(Date:7/29/2014)... (HealthDay News) -- Although the bite of a brown ... if left alone, an expert notes. It,s still ... reaction to a brown recluse spider bite, warned Dr. ... particularly since these potentially dangerous bites are on the ... to do nothing. The [bite] has classic characteristics, but ...
(Date:7/29/2014)... Angeles, CA (PRWEB) July 29, 2014 ... the website of Time Magazine titled “From Kim’s Butt ... Kim Kardashian’s butt is the celebrity feature ... and their features include Beyoncé’s butt, Jennifer Lawrence’s ... lips. This information is based on data collected by ...
(Date:7/29/2014)... (July 29, 2014) Using quality improvement measures in ... England Cardiovascular Disease Study Group, researchers have found a ... procedure with contrast dye. , Currently, 7-15 percent of ... contrast-dye end up with kidney injury, which can result ... to temporary or permanent dialysis, says a study published ...
Breaking Medicine News(10 mins):Health News:Good outcomes with multiple limb salvage after severe combat injuries, reports Plastic and Reconstructive Surgery 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 3Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Celebrity Plastic Surgery: Kim Kardashian’s Butt Tops the List of Celebrity Plastic Surgery Requests 2Health News:Reducing kidney injury using a quality improvement method 2
... Disease are more likely to display abnormal social behaviour ... are pathological gamblers, according to research in the January ... A number of studies have already associated pathological ... impulse control disorder associated mainly with dopamine replacement therapy. ...
... which have no tangible existence, arise out of physical ... Institute of Science provided evidence, for the first time, ... experience of seeing. In research recently published in ... research student Lior Fisch of the Weizmann Institute,s Neurobiology ...
... simple and inexpensive eye test could aid detection and diagnosis ... stage than is currently possible, according to new research by ... & Stephen Moss and published today in Cell Death ... and therefore brain cell death, to be directly measured in ...
... ... ... SonRidge, LLC, a catering and chef supplies company located in Western Massachusetts, found themselves in ... industry. What they discovered was an innovative resolution that not only solved an issue for ...
... , , EUGENE, Ore. , ... group gaining national recognition for its unprecedented work, has released ... Preventing HIV/AIDS for Women with Intellectual Disabilities. , With AIDS ... 25 - 44 in the United States , this ...
... ... DRE Velocity EKG, a portable PC-based EKG/ECG system that provides powerful data and analysis functions. ... (Vocus) January 14, 2010 ... —offers the DRE Velocity EKG , a 12-channel PC-based EKG system that provides impressive ...
Cached Medicine News:Health News:Parkinson's patients who are pathological gamblers also display abnormal social behavior 2Health News:To see or not to see 2Health News:Seeing a diagnosis: How an eye test could aid Alzheimer's detection 2Health News:Insulated Transport Containers Go Green 2Health News:The Tech-Aid Institute Releases HIV/AIDS Prevention Software for Women with Intellectual Disabilities 2Health News:Cost-effective PC-based EKG Now Available from DRE 2Health News:Cost-effective PC-based EKG Now Available from DRE 3
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... Cauteries provide a broad selection ... in a wide variety of ... cautery is packaged sterile, complete ... lock switch in the "off ...
Medicine Products: